Rebeccamycin [93908-02-2]
Cat# HY-19825-500ug
Size : 500ug
Brand : MedChemExpress
Description |
Rebeccamycin, an antitumor antibiotic, inhibits DNA topoisomerase I. Rebeccamycin appears to exert its primary antineoplastic effect by poisoning topoisomerase I and has negligible effect on protein kinase C and topoisomerase II[1][2]. |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IC50 & Target[1] |
|
|||||||||||||||
Cellular Effect |
|
|||||||||||||||
In Vitro |
Rebeccamycin is an antitumor antibiotic produced by the actinomycete Saccharotrix aerocolonigenes with activity against several human tumor cell lines, including A549 (lung adenocarcinoma), HCT-116 (colon carcinoma), and KB (nasopharyngeal carcinoma) [1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. |
|||||||||||||||
In Vivo |
Rebeccamycin (2-256 mg/kg; i.p.; daily for 9 days) prolongs survival in B16 melanoma, L1210 leukemia[2]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
|
|||||||||||||||
Molecular Weight |
570.38 |
|||||||||||||||
Formula |
C27H21Cl2N3O7 |
|||||||||||||||
CAS No. | ||||||||||||||||
SMILES |
O=C(N1)C(C2=C3N([C@@H]([C@@H]([C@@H](O)[C@@H]4OC)O)O[C@@H]4CO)C5=C2C=CC=C5Cl)=C(C(C6=CC=C7)=C3NC6=C7Cl)C1=O |
|||||||||||||||
Structure Classification | ||||||||||||||||
Initial Source |
the mycelium |
|||||||||||||||
Shipping | Room temperature in continental US; may vary elsewhere. |
|||||||||||||||
Storage |
Please store the product under the recommended conditions in the Certificate of Analysis. |
|||||||||||||||
Purity & Documentation | ||||||||||||||||
References |
|